---
schema_version: "secwatch.filing_event.v1"
accession: "0001731122-24-001539"
form_type: "8-K"
ticker: null
cik: "0001708331"
company_name: "Virpax Pharmaceuticals, Inc."
filed_at: "2024-10-03T23:59:59+00:00"
generated_at: "2026-05-30T21:36:28.597691+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Virpax appoints board member Katharyn Field as Vice President and principal executive officer

## Summary
- Katharyn Field appointed VP and principal executive officer effective Sept. 27, 2024.
- Field will continue to serve as a member of the Board of Directors.
- Company is an emerging growth company; no prior CEO departure noted.

## SEC filing metadata
- accession: 0001731122-24-001539
- form_type: 8-K
- cik: 0001708331
- company_name: Virpax Pharmaceuticals, Inc.
- filed_at: 2024-10-03T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1708331/000173112224001539/0001731122-24-001539-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1708331/000173112224001539/e6005_8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001731122-24-001539
- JSON: https://secwatch.observer/filing/0001731122-24-001539.json
- Plain text: https://secwatch.observer/filing/0001731122-24-001539.txt

## Key facts
- Executive change
  Katharyn Field was appointed as Vice President (principal executive officer) at Virpax Pharmaceuticals, Inc..
  - Action: appointed
  - Role: Vice President (principal executive officer)
  source text: On September 27, 2024, the Board of Directors (the “Board”) of Virpax Pharmaceuticals, Inc. (the “Company”) appointed Katharyn Field, a member of the Board, to also serve as a Vice President (principal executive officer) of the Company, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1708331/000173112224001539/0001731122-24-001539-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.